P Bagnarelli

Author PubWeight™ 36.57‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Analysis of HIV-1 load in blood, semen and saliva: evidence for different viral compartments in a cross-sectional and longitudinal study. AIDS 1996 2.41
2 Quantitative PCR and RT-PCR in virology. PCR Methods Appl 1993 2.20
3 Absolute quantitation of viremia in human immunodeficiency virus infection by competitive reverse transcription and polymerase chain reaction. J Clin Microbiol 1992 1.85
4 Hemophilia and nonprogressing human immunodeficiency virus type 1 infection. Blood 1997 1.41
5 Homozygous delta 32 deletion of the CCR-5 chemokine receptor gene in an HIV-1-infected patient. AIDS 1997 1.32
6 Quantitation of hepatitis C virus genome molecules in plasma samples. J Clin Microbiol 1994 1.12
7 Trans-activation of epidermal growth factor receptor gene by the hepatitis B virus X-gene product. Virology 1993 1.04
8 Defective nef alleles in a cohort of hemophiliacs with progressing and nonprogressing HIV-1 infection. Virology 1999 1.03
9 Clinical use of quantitative molecular methods in studying human immunodeficiency virus type 1 infection. Clin Microbiol Rev 1996 1.02
10 Rapid spread of the novel respiratory syncytial virus A ON1 genotype, central Italy, 2011 to 2013. Euro Surveill 2014 0.95
11 Molecular surveillance of pandemic influenza A(H1N1) viruses circulating in Italy from May 2009 to February 2010: association between haemagglutinin mutations and clinical outcome. Euro Surveill 2010 0.94
12 Sequence analysis of the hepatitis B virus pre-C region in hepatocellular carcinoma [HCC] and nontumoral liver tissues from HCC patients. Virology 1992 0.92
13 Clearance of HIV-1 viraemia after seroconversion. Lancet 1993 0.91
14 Clinical implications of HIV dynamics and drug resistance in macrophages. J Biol Regul Homeost Agents 1998 0.90
15 Immunity assessment in the early stages of amyotrophic lateral sclerosis: a study of virus antibodies and lymphocyte subsets. Acta Neurol Scand 1988 0.90
16 A single-step DNA extraction procedure for the detection of serum hepatitis B virus sequences by the polymerase chain reaction. J Virol Methods 1991 0.89
17 Quantitative molecular methods in virology. Arch Virol 1995 0.89
18 Competitive polymerase chain reaction and analysis of viral activity at the molecular level. Genet Anal Tech Appl 1994 0.87
19 Evolution of transmitted HIV-1 drug resistance in HIV-1-infected patients in Italy from 2000 to 2010. Clin Microbiol Infect 2012 0.86
20 Resistance and replicative capacity of HIV-1 strains selected in vivo by long-term enfuvirtide treatment. New Microbiol 2004 0.86
21 Changes in CD8 cell subpopulations induced by antiretroviral therapy in human immunodeficiency virus infected patients. Viral Immunol 1997 0.85
22 Prevalence of multiple dideoxynucleoside analogue resistance (MddNR) in a multicenter cohort of HIV-1-infected Italian patients with virologic failure. J Acquir Immune Defic Syndr 2000 0.84
23 Rare mutations in a domain crucial for V3-loop structure prevail in replicating HIV from long-term non-progressors. AIDS 1998 0.84
24 Diagnosis of human rotavirus infections: comparison of an electrophoretic method, a modified complement fixation test and electron microscopy for rotavirus detection. Arch Virol 1981 0.82
25 Comparable biological and molecular determinants in HIV type 1-infected long-term nonprogressors and recently infected individuals. AIDS Res Hum Retroviruses 1997 0.81
26 Early increase of CD4+ CD45RA+ and CD4+ CD95- cells with conserved repertoire induced by anti-retroviral therapy in HIV-infected patients. Clin Exp Immunol 1998 0.81
27 Reductions in viral load and increases in T lymphocyte numbers in treatment-naive patients with advanced HIV-1 infection treated with ritonavir, zidovudine and zalcitabine triple therapy. Antivir Ther 1997 0.81
28 Human immunodeficiency virus type 1 and hepatitis B virus transcription in peripheral blood lymphocytes from co-infected subjects. Arch Virol 1992 0.81
29 A combination of nucleoside analogues and a protease inhibitor reduces HIV-1 RNA levels in semen: implications for sexual transmission of HIV infection. Antivir Ther 1999 0.81
30 Genotypic testing on HIV-1 DNA as a tool to assess HIV-1 co-receptor usage in clinical practice: results from the DIVA study group. Infection 2013 0.79
31 Detection of hepatitis B virus DNA in serum using synthetic non-radioactive oligonucleotides. J Clin Pathol 1989 0.79
32 Complexity and dynamics of HIV-1 quasispecies. J Biol Regul Homeost Agents 2000 0.78
33 Expression of high- and low-affinity epidermal growth factor receptors in human hepatoma cell lines. FEBS Lett 1989 0.78
34 Differential response of the human hepatoma-derived cell line HA22T/VGH to polypeptide mitogens. FEBS Lett 1987 0.76
35 Intra-host evolution of human immunodeficiency virus type 1 and viral fitness. New Microbiol 2004 0.76
36 Early increase in cell-associated HIV-1 DNA in patients on highly active antiretroviral therapy. AIDS 1998 0.76
37 Quantitative techniques and HIV-1 load in plasma and semen. AIDS 1998 0.75
38 Patterns of in vitro anti-human immunodeficiency virus type 1 antibody production in long-term nonprogressors. Clin Immunol Immunopathol 1997 0.75
39 A serum-free growth of a human hepatoma cell line as a tool for hepatocarcinogenesis and virus gene expression. Dev Biol Stand 1985 0.75
40 Complement-fixation test for rotavirus detection: comparison and analysis of different methods to reduce anti-complementary activity of some specimens. J Virol Methods 1982 0.75
41 Insulin reduces HBsAg production by PLC/PRF/5 human hepatoma cell line. Brief report. Arch Virol 1984 0.75
42 [Acute respiratory infections caused by viruses, mycoplasmas, rickettsias and chlamydias with bronchial and pulmonary localization. 2 year's experience in the province of Ancona]. Minerva Med 1982 0.75
43 [Respiratory tract infections caused by viruses, Mycoplasma, Rickettsia and Chlamydia with bronchial and pulmonary localization]. Minerva Med 1984 0.75
44 [Adaptation to defined chemical conditions of the in vitro growth of PLC/PRF/5 cells]. Boll Soc Ital Biol Sper 1985 0.75
45 Serum-free growth of human hepatoma cells. A review. Adv Biochem Eng Biotechnol 1987 0.75
46 [Cross-over electrophoresis on cellulose acetate. A new method for rapid diagnosis of rotavirus infection]. Boll Ist Sieroter Milan 1980 0.75
47 Molecular monitoring of human immunodeficiency virus type 1 infection. J Biol Regul Homeost Agents 1998 0.75
48 Immune reconstitution in HIV-1 infected children with discordant response to antiretroviral therapies: patterns of HIV-1 env gene evolution driven by restoration of thymic function. New Microbiol 2004 0.75
49 Human growth hormone induced modulation of hepatitis B virus (HBV) gene expression. Dev Biol Stand 1987 0.75
50 Identification of two distinct subsets of long-term nonprogressors with divergent viral activity by stromal-derived factor 1 chemokine gene polymorphism analysis. J Infect Dis 1999 0.75
51 [Hepatocarcinoma cell lines in vitro: binding of insulin]. Boll Soc Ital Biol Sper 1987 0.75
52 Quantitative evaluation of the recombinant HIV-1 phenotype to protease inhibitors by a single-step strategy. AIDS 2000 0.75
53 A human hepatoma cell line modulates its insulin receptors under different culture conditions. Boll Soc Ital Biol Sper 1985 0.75
54 Induced underglycosylation of PLC/PRF/5 human hepatoma cells. Brief report. Arch Virol 1983 0.75
55 Hemophilia and nonprogressing human immunodeficiency virus type 1 infection. Haemophilia 1997 0.75
56 Characterization of growth parameters of a human hepatoma cell line cultured under serum-free conditions. Ric Clin Lab 1985 0.75
57 [Pulmonitis caused by Coxiella burneti and Chlamydia psittaci. 2 years of research in Marche]. Boll Ist Sieroter Milan 1984 0.75
58 Effect of steroids and adenine-arabinoside (araA) on growth and HBsAg production of a human hepatoma cell line. Arch Virol 1983 0.75
59 Comparative effects of alpha, beta and gamma human interferons on a HBsAg-producing human hepatoma cell line. Ric Clin Lab 1987 0.75
60 [Evaluation of the antiviral and cellular antireplication effect of human interferon on a line of primary hepatocarcinoma]. G Ital Chemioter 1986 0.75
61 Effect of insulin on an insulin receptor of PLC/PRF/5 human hepatoma cell line. Dev Biol Stand 1985 0.75
62 Modulation of production of hepatitis B surface antigen by a human hepatoma cell line. J Med Virol 1984 0.75
63 Lack of detectable human T-cell lymphotropic virus type I sequences in samples from multiple sclerosis patients. J Med Virol 1992 0.75
64 Quantitation of HIV-1 genome copy number in semen and saliva. AIDS 1995 0.75